OpenEvidence Soars: AI for Doctors Doubles Valuation to $12 Billion!
Analysis
OpenEvidence is revolutionizing healthcare with its AI platform, providing doctors with an incredible 'brain extender.' The recent $250 million Series D funding and valuation doubling to $12 billion are testaments to its success and promising future in the medical field.
Key Takeaways
Reference
“OpenEvidence announced Wednesday it has raised $250 million in a Series D funding round that doubled its valuation to $12 billion.”